Overview

Leflunomide Treatment for IgG4-RD

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

This study is an open-label randomized controlled trial aiming to investigate whether the efficacy and side effect of Leflunpomide plus glucocorticoid.

Phase:

N/A

Details

Lead Sponsor:

Peking Union Medical College Hospital

Treatments:

Leflunomide
Prednisone